BackAcer Therapeutics Overview

Acer Therapeutics Current Assets

Latest current assets for ACER: $6.1M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$6.14M
15.93% YoYΔ $-1.16M vs prior year quarter

Peer trimmed avg / median

Loading

Acer Therapeutics Current Assets History

Loading

Acer Therapeutics vs. peers: Current Assets Comparison

Loading

Acer Therapeutics Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Acer Therapeutics (ACER) FAQ

As of the most recent data (September 2023), ACER shows a current assets of $6.1M. That compares with $7.3M in the prior-year period — down 15.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ACER's current assets is now $6.1M (was $7.3M) — a 15.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Acer Therapeutics is outperforming or lagging.

Tracking ACER's current assets over time shows whether Acer Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $6.1M That compares with $7.3M in the prior-year period — down 15.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Acer Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $6.1M) with ownership activity and broader fundamentals.

Acer Therapeutics's current assets is $6.1M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.